VHPB Centre for Evaluation of Vaccination (CEV) |
Executive Secretary Administrative and Scientific Secretariat |
privacy statement
|
Athens, Greece, November 15-16, 2007
Thursday, November 15, 2007
Session 1 Opening and objectives
Chair: V Papaevangelou - P Van Damme
09.00 - 09.30
Session 2 The health care system in Greece
Chair: E Manesis - P Bonanni
09.30 - 09.50
Organisation of the health care system and financement in Greece 276 Kb (.pdf)
Y Tountas
09.50 - 10.10
National program for viral hepatitis prevention and control 247 Kb (.pdf)
J Pierroutsakos - A Zisouli
10.10 - 10.30
HBV immunization policies 199 Kb (.pdf)
A Konstantopoulos - V Papaevangelou
10.30 - 10.50
Coffee Break
Session 3 Surveillance systems in Greece
Chair: C Hadjichristodoulou - H Blystad
10.50 -11.10
Overview of HAV, HBV, and HCV surveillance 316 Kb (.pdf)
G Nikolopoulou
11.10 - 11.30
Experience gained from Surveillance of Infectious Diseases during the Olympics. How can we extend it to real life? 951 Kb (.pdf)
S Tsiodras
11.30 - 11.50
Vaccination uptake 189 Kb (.pdf)
T Panagiotopoulos
11.50 - 12.10
Migration and viral hepatitis 199 Kb (.pdf)
C Hadjichristodoulou – V Vasilopoulou
12.10 - 12.30
Surveillance in Blood Bank 234 Kb (.pdf)
A Varaklioti
12.30-14.15
Lunch
Session 4 Epidemiology of viral hepatitis in Greece
Chair: I Vafiadou - W Jilg
14.15 - 14.40
Epidemiology of hepatitis B and D in Greece 348 Kb (.pdf)
G Papatheodoridis
14.40 - 15.00
Epidemiology of hepatitis C in Greece
M Raptopoulou-Gigi
15.00 - 15.30
Epidemiology of hepatitis A and E in Greece 274 Kb (.pdf)
V Papaevangelou
15.30 - 16.00
National Seroprevalence Study: Discussion of different approaches 229 Kb (.pdf)
G Touloumi
16.00 - 16.20
Discussion
16.20 – 16.45
EUVAC.NET’s activities: Expectations and Results 1.2 Mb (.pdf)
M Muscat
16.45
Close of the day
Friday, November 16, 2007
Session 5 Prevention and control of viral hepatitis in Greece
Chair: S Hadziyannis - F Roudot-Thoraval
09.00 - 09.20
Cohort of HBV and HCV patients 442 Kb (.pdf)
E Manesis
09.20 - 09.50
Molecular epidemiology of HBV and HCV infection in Greece 2.9 Mb (.pdf)
D Paraskevis
09.50 - 10.20
Viral hepatitis coinfection in HIV-infected patients 1.14 Mb (.pdf)
I Baraboutis
10.20 - 10.40
Discussion and lessons learnt
10.40 - 11.00
Coffee break
Session 6 Hepatitis A vaccination programmes
Chair: S Badur – D Lavanchy
11.00 - 11.20
The hepatitis A vaccination programme in Greece. Targeted versus Universal immunization 443 Kb (.pdf)
V Papaevangelou
11.20 – 11.40
Hepatitis A universal vaccination: the Israel experience 310 Kb (.pdf)
D Shouval
11.40 – 12.00
Discussions and lessons learnt
12.00 – 13.30
Lunch
Session 7 Conclusions of the meeting
Chair: D Shouval – S Wiersma
13.30 - 15.00
Preliminary meeting conclusions 181 Kb (.pdf)
P Van Damme
15.00 Close of the meeting